Business
Intelligence for founders, operators, and investors building sustainable cannabis ventures.
Business · page 3
- Medical Cannabis
Curaleaf Becomes First to Register Cannabis Preparations Under Spain’s New Medical Framework
Spain’s medicines regulator has officially approved the first two oil-based preparations as part of its recently approved national medical cannabis scheme.
- Pharmaceutical
World’s Largest CBD Insomnia Trial Could Hand Avecho an Australian Monopoly
The world’s largest clinical trial on cannabidiol (CBD) as a treatment for insomnia has been given the green light to complete its Phase III trial, transforming the fortunes of Avecho Biotechnology, and potentially the lives of insomnia sufferers worldwide.
- Cultivation
‘No Right to GMP Washing’: German State Challenges Cannabis Flower Import Compliance
Authorities from the German state of Hesse have taken aim at the practice of ‘GMP washing’ in its thriving medical cannabis market, an intervention that could have significant implications for the industry at large.
- Cultivation
Northern Leaf and 3R Biotech Launch Europe’s First Single-Site Cannabis Plant Health Facility in Jersey
Northern Leaf has partnered with Canadian biotech firm 3R Biotech to open 3R Europe, a facility combining cannabis plant testing, cleaning, preservation and reproduction at a single site for the first time in Europe.
- Medical Cannabis
Curaleaf Laboratories and Herdade das Barrocas (HDB) Announce Strategic Partnership to Reintroduce HDB Products to the UK Medical Cannabis Market
Curaleaf Laboratories, one of the UK’s leading manufacturers and distributors of EU-GMP medical cannabis products and Herdade das Barrocas (HDB), a Portuguese cultivator known for its cannabis genetics and cultivation expertise, are pleased to announce a new manufacturing and supply partnership that will see HDB products reintroduced to healthcare professionals and patients across the United…
- Interviews
From Land to Brand: Why Cannabis’s Next Generation Is Going Asset-Light
Last year (fiscal year 2024/2025), Canada’s legal cannabis industry recorded revenues of CA$5.5bn, according to the latest figures from Statistics Canada.
- Opinion
Europe’s Medical Cannabis Market Has Grown Up, Now Its Supply Chain Needs To
Written by Oskar Fletcher, Chief Executive of pharmaceutical contract manufacturing operator Blossom Pharma.
- Cultivation
PGP Farmer Launches 30-Variety Dutch Trial to Set Dordogne Production Blueprint
PGP Farmer, the French biotech developing what it describes as the country’s first EU-GMP medical cannabis production site, has launched a proof-of-concept phenotyping programme in the Netherlands, testing 30 cannabis genotypes from its own genetic library to determine which varieties will be cultivated at its Dordogne facility.
- Supply Chain
UK Medical Cannabis Imports Hit 30 Tonnes as Canadian Producers Bypass European Processors
Canadian producers shipped 17,067kg of medical cannabis directly to the UK in 2025, more than six times the 2,578kg recorded the year before, according to the latest official Home Office data seen by Business of Cannabis.
- Cultivation
Voices Of Cannabis Europa: Barry Laxer, founder and President of Cielo Verde
As we head into Cannabis Europa, Business of Cannabis chats with Barry Laxer, founder and President of Canadian cannabis producer Cielo Verde 26–27 May 2026 · Barbican, London Cannabis Europa Two days of policy, capital and clinical strategy at the Barbican — convening operators, investors, regulators and clinicians from across the European cannabis market.
- Interviews
Voices of Cannabis Europa: Nir Aloni, CEO of SafriCanna
Hana Hallaj from SafriCanna will also host a presentation entitled ‘Innovation in Cannabis’ at this year’s event.
- Medical Cannabis
Voices of Cannabis Europa: Sasho Stefanoski, CEO of PHCANN International
As we head into Cannabis Europa, Business of Cannabis chats with Sasho Stefanoski, CEO of PHCANN International. 26–27 May 2026 · Barbican, London Cannabis Europa Two days of policy, capital and clinical strategy at the Barbican — convening operators, investors, regulators and clinicians from across the European cannabis market.
